The novel phenylester anticancer compounds: Study of a derivative of aspirin (phoshoaspirin)

International Journal of Oncology

Volumn 32, Issue 1, 2008, Pages 97-100

  Rigas, Basil ^a   Kozoni, Vasiliki ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Aspirin; Cancer prevention; Cancer treatment; Colon cancer; Phosphoaspirin

Indexed keywords

3 [(DIETHOXYPHOSPHORYLOXY)METHYL)PHENYL 3 ACETOXYBENZOATE]; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 38749114969     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.32.1.97     Document Type: Article

References (8)

1. Rigas B: The use of nitric oxide-donating non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal neoplasia. Curr Opin Gastroenterol 23: 55-59, 2007.
2. Kashfi K and Rigas B: The mechanism of action of nitric oxide-donating aspirin. Biochem Biophys Res Commun 358: 1096-1101, 2007.
3. Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM, Rogers RS, Rogier DJ, Yu SS, Anderson GD, Burton EG, Cogburn JN, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Veenhuizen AW, Zhang YY and Isakson PC: Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclo-oxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, Celecoxib). J Med Chem 40: 1347-1365, 1997.
4. Kozoni V, Tsioulias G, Shiff S and Rigas B: The effect of lithocholic acid on proliferation and apoptosis during the early stages of colon carcinogenesis: differential effect on apoptosis in the presence of a colon carcinogen. Carcinogenesis 21: 999-1005, 2000.
5. Ben-Sasson SA, Sherman Y and Gavrieli Y: Identification of dying cells - in situ staining. Methods Cell Biol 46: 29-39, 1995.
6. Kashfi K, Borgo S, Williams JL, Chen J, Gao J, Glekas A, Benedini F, Del Soldato P and Rigas B: Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo. J Pharmacol Exp Ther 312: 978-988, 2005.
7. Williams JL, Kashfi K, Ouyang N, del Soldato P, Kopelovich L and Rigas B: NO-donating aspirin inhibits intestinal carcinogenesis in Min [APC(Min/+)] mice. Biochem Biophys Res Commun 313: 784-788, 2004.
8. Rao CV, Reddy BS, Steele VE, Wang CX, Liu X, Ouyang N, Patlolla JM, Simi B, Kopelovich L and Rigas B: Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets. Mol Cancer Ther 5: 1530-1538, 2006.